EP0464137A4 - Inhibition of hiv using synergistic combinations of nucleoside derivatives - Google Patents

Inhibition of hiv using synergistic combinations of nucleoside derivatives

Info

Publication number
EP0464137A4
EP0464137A4 EP19900905787 EP90905787A EP0464137A4 EP 0464137 A4 EP0464137 A4 EP 0464137A4 EP 19900905787 EP19900905787 EP 19900905787 EP 90905787 A EP90905787 A EP 90905787A EP 0464137 A4 EP0464137 A4 EP 0464137A4
Authority
EP
European Patent Office
Prior art keywords
hiv
inhibition
nucleoside derivatives
synergistic combinations
synergistic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19900905787
Other versions
EP0464137A1 (en
Inventor
Vera Brankovan
Richard J. White
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncogen LP
Original Assignee
Oncogen LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oncogen LP filed Critical Oncogen LP
Publication of EP0464137A1 publication Critical patent/EP0464137A1/en
Publication of EP0464137A4 publication Critical patent/EP0464137A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
EP19900905787 1989-03-17 1990-03-16 Inhibition of hiv using synergistic combinations of nucleoside derivatives Withdrawn EP0464137A4 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US32493489A 1989-03-17 1989-03-17
US324934 1989-03-17
US40190889A 1989-09-01 1989-09-01
US401908 1989-09-01

Publications (2)

Publication Number Publication Date
EP0464137A1 EP0464137A1 (en) 1992-01-08
EP0464137A4 true EP0464137A4 (en) 1992-01-15

Family

ID=26984692

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19900905787 Withdrawn EP0464137A4 (en) 1989-03-17 1990-03-16 Inhibition of hiv using synergistic combinations of nucleoside derivatives

Country Status (19)

Country Link
EP (1) EP0464137A4 (en)
JP (1) JPH04504850A (en)
KR (1) KR920700653A (en)
CN (1) CN1045791A (en)
AU (1) AU5351490A (en)
CA (1) CA2050473A1 (en)
DD (1) DD301787A9 (en)
FI (1) FI914367A0 (en)
GR (1) GR1000618B (en)
HU (1) HU208254B (en)
IL (1) IL93783A0 (en)
NO (1) NO913659L (en)
NZ (1) NZ232912A (en)
OA (1) OA09555A (en)
PL (1) PL284343A1 (en)
PT (1) PT93449A (en)
WO (1) WO1990011081A1 (en)
YU (1) YU53790A (en)
ZW (1) ZW3290A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1992020344A1 (en) * 1991-05-16 1992-11-26 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
BR9911457A (en) * 1998-06-24 2001-12-11 Univ Emory Use of 3'-azide-2 ', 3'-dideoxyuridine in combination with additional anti-HIV drugs for the manufacture of a drug for the treatment of HIV
WO2002074910A2 (en) 2001-03-15 2002-09-26 Trustees Of Boston College, The Selective anti-viral nucleoside chain terminators

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases
GB8712115D0 (en) * 1987-05-22 1987-06-24 Hoffmann La Roche Pyrimidine derivatives
US4837311A (en) * 1987-06-22 1989-06-06 Hoffman-La Roche Inc. Anti-retroviral compounds
NZ226672A (en) * 1987-10-30 1991-07-26 Hoffmann La Roche 6-amino-9-(2,3-dideoxy-2-fluoro-b-d-threopentofuranosyl)-9h-purine derivatives and pharmaceutical compositions
US4908440A (en) * 1987-11-12 1990-03-13 Bristol Myers Company 2',3'-dideoxy-2'-fluoroarabinopyrimidine nucleosides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
No further relevant documents have been disclosed. *

Also Published As

Publication number Publication date
NO913659L (en) 1991-10-18
GR900100189A (en) 1990-07-31
CN1045791A (en) 1990-10-03
ZW3290A1 (en) 1990-11-07
NZ232912A (en) 1992-06-25
EP0464137A1 (en) 1992-01-08
HUT57988A (en) 1992-01-28
GR1000618B (en) 1992-08-31
IL93783A0 (en) 1990-12-23
CA2050473A1 (en) 1990-09-18
WO1990011081A1 (en) 1990-10-04
KR920700653A (en) 1992-08-10
HU902898D0 (en) 1991-12-30
PT93449A (en) 1990-11-07
YU53790A (en) 1993-05-28
OA09555A (en) 1993-01-31
FI914367A0 (en) 1991-09-17
JPH04504850A (en) 1992-08-27
NO913659D0 (en) 1991-09-17
HU208254B (en) 1993-09-28
PL284343A1 (en) 1991-06-03
DD301787A9 (en) 1994-01-13
AU5351490A (en) 1990-10-22

Similar Documents

Publication Publication Date Title
GB2212498B (en) Adenosine derivatives
NZ225542A (en) Avermectin derivatives and parasiticidal compositions
NZ222527A (en) N 9 -cyclopentyl-substituted adenosine derivatives and intermediate compound and pharmaceutical compositions
AU3978689A (en) Nucleoside derivatives
GR3003177T3 (en) Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
EP0432600A3 (en) Derivatives of 2-iminopyridine
NZ223272A (en) Avermectin derivatives and parasiticidal compositions
NZ223771A (en) Avermectin derivatives and parasiticidal compositions
HU9300032D0 (en) Phenyl-acetamide derivatives of hiv inhibiting effect
IL99843A0 (en) Synergistic combination of hiv reverse transcriptase inhibitors
IL91415A0 (en) Pharmaceutical compositions containing adenosine derivatives
GB9320785D0 (en) Dibenzylheterocyclic or dibenzylcycloalkyl derivatives as inhibitors of hiv intergrase
GB2333292B (en) Derivatives of hexaazoisowurtzitane
OA09697A (en) Nucleoside derivatives
NZ219250A (en) Purine derivatives and pharmaceutical compositions
IL93783A0 (en) Inhibition of hiv using synergistic combinations of nucleoside derivatives
EP0431799A3 (en) Use of nucleoside derivatives as cytotoxic agents
YU53490A (en) Derivatives of tetrahydronaphtaline
ZA901961B (en) Inhibition of hiv using synergistic combinations of nucleoside derivatives
EP0450102A4 (en) Nucleoside derivative
IE900934L (en) Inhibition of hiv using synergistic combinations of¹nucleosides
IL101084A0 (en) Preparation of nucleoside derivatives
GB8925039D0 (en) Nucleoside derivatives
GB8925037D0 (en) Nucleoside derivatives
CS56288A1 (en) Derivatives of adenine

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19910918

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19911125

AK Designated contracting states

Kind code of ref document: A4

Designated state(s): AT BE CH DE DK ES FR GB IT LI LU NL SE

17Q First examination report despatched

Effective date: 19930309

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 19930921